Sunday, August 27, 2023 4:49:39 PM
To be fair, I can understand people's anger at management (and you know I'm a real long).
They were dealt an absolutely brutal hand with the whole pseudo-progression business in 2016. They did what they had to do to keep the company afloat, and that includes not being totally upfront about timelines and risks with the PIII trial. Most people had no idea that trial would take another 5 years and thought TLD was just around the corner. A lot of major players lost a lot of money (i.e. Woodford). I forgave them for it... many did not.
A lot of people have a bad taste in their mouth and are terrified they'll do the same thing with MAA. I don't see it that way - they have the data they need to get this approved - they just need to package it in the right format and send it on its way.
They were dealt an absolutely brutal hand with the whole pseudo-progression business in 2016. They did what they had to do to keep the company afloat, and that includes not being totally upfront about timelines and risks with the PIII trial. Most people had no idea that trial would take another 5 years and thought TLD was just around the corner. A lot of major players lost a lot of money (i.e. Woodford). I forgave them for it... many did not.
A lot of people have a bad taste in their mouth and are terrified they'll do the same thing with MAA. I don't see it that way - they have the data they need to get this approved - they just need to package it in the right format and send it on its way.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
